Reimagining Care Delivery with Precision and Data

Leandro Boer, Vice President of US Medical and General Medicines at Amgen, emphasizes the critical role of data in this transformation. The company is actively working to prevent “data waste” by leveraging multi-omics and advanced analytics to gain deeper insights into disease mechanisms and individual patient needs. This approach allows for the development of more targeted therapies and personalized treatment plans.

Amgen’s commitment to innovation is underscored by its $600 million Innovation and Discovery Science Center, a hub for cutting-edge research. This investment reflects a broader strategy to accelerate drug development and bring life-changing therapies to patients faster. Technology, particularly machine learning, is playing an increasingly vital role in streamlining clinical trials, reducing timelines, and improving efficiency.

The Future of Healthcare: Three Key Shifts

Looking ahead, Boer anticipates three major shifts within the next five years. First, drug development will accelerate, fueled by advancements in genomics and data science. Second, the administrative burden on healthcare providers will be significantly reduced through the implementation of artificial intelligence (AI). Finally, improved patient identification via care pathway automation will ensure that the right patients receive the right care at the right time.

Amgen has set an ambitious goal to reduce cardiovascular events by 50% by 2030. Achieving this requires a multifaceted approach, including the development of novel therapies and a commitment to equitable access to care. The company’s RISE initiative is a testament to this commitment, focusing on increasing diversity in clinical trials to ensure that research findings are representative of the broader population.

Beyond scientific innovation, Amgen recognizes the importance of a thriving workforce. The company prioritizes employee well-being, understanding that a healthy and engaged team is essential for delivering exceptional patient care. But what role does fostering a positive internal culture play in driving external innovation and patient outcomes? And how can other organizations replicate Amgen’s success in prioritizing both employee and patient well-being?

Amgen’s approach extends beyond simply treating illness; it’s about proactively preventing disease and improving overall health. This requires a collaborative effort involving researchers, clinicians, policymakers, and, most importantly, patients.

Learn more about Amgen’s work by visiting their website and following them on LinkedIn. Connect with Leandro Boer on LinkedIn to continue the conversation.

Further insights into the evolving landscape of healthcare innovation can be found at The New England Journal of Medicine and The World Health Organization.

Frequently Asked Questions About Amgen’s Healthcare Innovations

• What is precision medicine, and how is Amgen utilizing it?

  Precision medicine involves tailoring medical treatment to the individual characteristics of each patient. Amgen is leveraging genomics, proteomics, and other “omics” technologies to develop targeted therapies and personalized treatment plans.

• How is Amgen addressing the issue of diversity in clinical trials?

  Amgen’s RISE initiative is dedicated to increasing representation of diverse populations in clinical trials, ensuring that research findings are applicable to a broader range of patients.

• What role does artificial intelligence (AI) play in Amgen’s future healthcare strategy?

  AI is expected to significantly reduce the administrative burden on healthcare providers, automate care pathways, and accelerate drug development processes.

• What is Amgen’s goal regarding cardiovascular events, and how are they working to achieve it?

  Amgen aims to reduce cardiovascular events by 50% by 2030 through the development of innovative therapies and a commitment to preventative care.

• How does Amgen prioritize employee well-being, and why is this important?

  Amgen recognizes that a healthy and engaged workforce is crucial for delivering exceptional patient care. Prioritizing employee well-being fosters innovation and improves overall organizational performance.